T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity

Endocrine

Volumn 52, Issue 1, 2016, Pages 30-38

  González Amaro, Roberto ^a   Marazuela, Mónica ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Autoimmune thyroid disease; Cytokines; Immune regulation; T cells

Indexed keywords

CD161 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MULTIDRUG RESISTANCE PROTEIN 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; AUTOIMMUNE THYROIDITIS; CYTOKINE RESPONSE; HUMAN; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ANIMAL; IMMUNOLOGY; PATHOLOGY; THYROID GLAND;

ANIMALS; HUMANS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 84945218181     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0759-7     Document Type: Review

References (95)

1. A. Antonelli, S.M. Ferrari, A. Corrado, A. Di Domenicantonio, P. Fallahi, Autoimmune thyroid disorders. Autoimmun. Rev. 14, 174–180 (2015)
2. S.A. Morshed, R. Latif, T.F. Davies, Delineating the autoimmune mechanisms in Graves’ disease. Immunol. Res. 54, 191–203 (2012)
3. H. Li, T. Wang, The autoimmunity in Graves’ disease. Front. Biosci. 18, 782–787 (2013)
4. Y. Wang, T.J. Smith, Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest. Ophthalmol. Vis. Sci. 55, 1735–1748 (2014)
5. L. Bartalena, V. Fatourechi, Extrathyroidal manifestations of Graves’ disease: a 2014 update. J. Endocrinol. Invest. 37, 691–700 (2014)
6. L.A. Zúñiga, R. Jain, C. Haines, D.J. Cua, Th17 cell development: from the cradle to the grave. Immunol. Rev. 252, 78–88 (2013)
7. C.R. Grant, R. Liberla, G. Mieli-Vergani, D. Vergani, M.S. Longhi, Regulatory T-cells in autoinmune diseases: challenges, controversies and-yet-unanswered questions. Autoimmun. Rev. 14, 105–116 (2015)
8. A.L. Croxford, P. Kulig, B. Becher, IL-12 and IL-23 in health and disease. Cytokine Growth Factor Rev. 25, 415–421 (2014)
9. R.K. Gershon, K. Kondo, Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723–737 (1970)
10. S. Hori, T. Takahashi, S. Sakaguchi, Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81, 331–371 (2003)
11. M. Miyara, Y. Ito, S. Sakaguchi, Treg-cell therapies for autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 10, 543–551 (2014)
12. S. Sakaguchi, D.A. Vignali, A.Y. Rudensky, R.E. Niec, H. Waldmann, The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13, 461–467 (2013)
13. S. Sakaguchi, K. Wing, Y. Onishi, P. Prieto-Martin, T. Yamaguchi, Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105–1111 (2009)
14. Y. Han, Q. Guo, M. Zhang, Z. Chen, X. Cao, CD69+ CD4+ CD25− T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-β1. J. Immunol. 182, 111–120 (2009)
15. M. Vitales-Noyola, L. Doníz-Padilla, C. Álvarez-Quiroga, A. Monsiváis-Urenda, H. Portillo-Salazar, R. González-Amaro, Quantitative and functional analysis of CD69(+) NKG2D(+) T regulatory cells in healthy subjects. Hum. Immunol. 76, 511–518 (2015)
16. M.G. Roncarolo, S. Gregori, R. Bacchetta, M. Battaglia, Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr. Top. Microbiol. Immunol. 380, 39–68 (2014)
17. M. Marazuela, M.A. García-López, N. Figueroa-Vega, H. de la Fuente, B. Alvarado-Sánchez, A. Monsiváis-Urenda, F. Sánchez-Madrid, R. González-Amaro, Regulatory T cells in human autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 91, 3639–3646 (2006)
18. P. Verginis, H.S. Li, G. Carayanniotis, Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+ CD25+ T cells. J. Immunol. 174, 7433–7439 (2005)
19. E. Gambineri, T.R. Torgerson, H.D. Ochs, Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of Foxp3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15, 430–435 (2003)
20. D.J. Kasprowicz, P.S. Smallwood, A.J. Tyznik, S.F. Ziegler, Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J. Immunol. 171, 1216–1223 (2003)
21. C. Mao, S. Wang, Y. Xiao, J. Xu, Q. Jiang, M. Jin, X. Jiang, H. Guo, G. Ning, Y. Zhang, Impairment of regulatory capacity of CD4+ CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves´ disease. J. Immunol. 186, 4734–4743 (2011)
22. M. Nakahara, Y. Nagayama, T. Ichikawa, L. Yu, G.S. Eisenbarth, N. Abiru, The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages. Autoimmunity 44, 504–510 (2011)
23. D. Pan, Y.H. Shin, G. Gopalakrishnan, J. Hennessey, L.J. De Groot, Regulatory T cells in Graves’ disease. Clin. Endocrinol. 71, 587–593 (2009)
24. P. Verginis, H.S. Li, G. Carayanniotis, Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+ CD25+ T cells. J. Immunol. 174, 7433–7439 (2005)
25. A.B. Glick, A. Wodzinski, P. Fu, A.D. Levine, D.N. Wald, Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 23, 871–878 (2013)
26. A. Bossowski, M. Moniuszko, M. Dabrowska, B. Sawicka, M. Rusak, M. Jeznach, J. Wójtowicz, A. Bodzenta-Lukaszyk, A. Bossowska, Lower proportions of CD4+ CD25high and CD4+ Foxp3+, but not CD4+ CD25+ CD127lowFoxp3+ T cell levels in children with autoimmune thyroid diseases. Autoimmune 46, 222–230 (2013)
27. A. Rodríguez-Muñoz, M. Vitales-Noyola, A. Ramos-Levi, A. Serrano-Somavilla, R. González-Amaro, M. Marazuela, Levels of regulatory T cells CD69+ NKG2D+ IL-10+ are increased in patients with autoimmune thyroid disorders. Endocrine (2015). doi:10.1007/s12020-015-0662-2
28. R. Basu, R.D. Hatton, C.T. Weaver, The Th17 family: flexibility follows function. Immunol. Rev. 252, 89–203 (2013)
29. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, S. Romagnani, Human T helper type 1 dichotomy: origin, phenotype and biological activities. Immunology 144, 343–351 (2014)
30. Y.K. Lee, R. Mukasa, R.D. Hatton, C.T. Weaver, Developmental plasticity of Th17 and Treg cells. Curr. Opin. Immunol. 21, 274–280 (2009)
31. G. Beriou, C.M. Costantino, C.W. Ashley, L. Yang, V.K. Kuchroo, C. Baecher-Allan, D.A. Hafler, IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113, 4240–4249 (2009)
32. pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340–2352 (2008)
33. H.J. Bovenschen, P.C. van de Kerkhof, P.E. van Erp, R. Woestenenk, I. Joosten, H.J. Koenen, Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 131, 1853–1860 (2011)
34. S.A. McClymont, A.L. Putnam, M.R. Lee, J.H. Esensten, W. Liu, M.A. Hulme, U. Hoffmüller, U. Baron, S. Olek, J.A. Bluestone, T.M. Brusko, Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J. Immunol. 186, 3918–3926 (2011)
35. P. Pandiyan, J. Zhu, Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells. Cytokine (2015). doi:10.1016/j.cyto.2015.07.005
36. R. Du, H. Zhao, F. Yan, H. Li, IL-17+ Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells. J. Leukoc. Biol. 96, 39–48 (2014)
37. L. Shi, M. Bi, R. Yang, J. Zhou, S. Zhao, C. Fan, Z. Shan, Y. Li, W. Teng, Defective expression of regulatory B cells in iodine-induced autoimmune thyroiditis in non-obese diabetic H-2(h4) mice. J. Endocrinol. Invest. 37, 43–50 (2014)
38. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, R.L. Coffman, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokines activities and secreted proteins. J. Immunol. 136, 2348–2357 (1986)
39. N. Schmitt, H. Ueno, Regulation of human helper T cell subset differentiation by cytokines. Curr. Opin. Immunol. 34, 130–136 (2015)
40. S. Aggarwal, N. Ghilardi, M.H. Xie, F.J. de Sauvage, A.L. Gurney, Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003)
41. E. Rouvier, M.F. Luciani, M.G. Mattei, F. Denizot, P. Golstein, CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445–5456 (1993)
42. Z. Yao, S.L. Painter, W.C. Fanslow, D. Ulrich, B.M. Macduff, M.K. Spriggs, R.J. Armitage, Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155, 5483–5486 (1995)
43. X. Song, H. Gao, Y. Qian, Th17 differentiation and their pro-inflammation function. Adv. Exp. Med. Biol. 841, 99–151 (2014)
44. C.L. Langrish, Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, D.J. Cua, IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233–240 (2005)
45. K. Ghoreschi, A. Laurence, X.P. Yang, C.M. Tato, M.J. McGeachy, J. Konkel, H.L. Ramos, L. Wei, T. Davidson, N. Bouladoux, J. Grainger, Q. Chen, Y. Kanno, W.T. Watford, H.W. Sun, G. Eberl, E. Schevach, Y. Belkaid, D.J. Cua, W. Chen, O´Shea, J.J.: Generation of pathogenic Th17 cells in the absence of TGF-β signaling. Nature 467, 967–971 (2010)
46. K. Ghoreschi, A. Laurence, X.P. Yang, K. Hirahara, J.J. O’Shea, T helper 17 cell heterogeneity and pathogenicity in autoinmune disease. Trends Immunol. 32, 395–401 (2011)
47. Y. Lee, A. Awasthi, N. Yosef, F.J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. Hafler, R.A. Sobel, A. Regev, V.K. Kuchroo, Induction and molecular signature of pathogenic Th17 cells. Nat. Immunol. 13, 991–999 (2012)
48. S.A. Basdeo, B. Moran, D. Cluxton, M. Canavan, J. McCormick, M. Connolly, C. Orr, K.H.G. Mills, D.J. Veale, U. Fearon, J.M. Fletcher, Polyfunctional, pathogenic CD161+ Th17 cells lineage cells are resistant to regulatory T cell-mediated suppression in the context of autoimmunity. J. Immunol. 195, 528–540 (2015)
49. R. Ramesh, L. Kozhaya, K. McKevitt, I.M. Djuretic, T.J. Carlson, M.A. Quintero, J.L. McCauley, M.T. Abreu, D. Unutmaz, M.S. Sundrud, Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J. Exp. Med. 211, 89–114 (2014)
50. T. Feng, A.T. Cao, C.T. Weaver, C.O. Elson, Y. Cong, Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 140, 2031–2043 (2011)
51. M.A. Kluger, M.C. Meyer, A. Nosko, B. Goerke, M. Luig, C. Wegscheid, G. Tiegs, R.A. Stahl, U. Panzer, O.M. Steinmetz, RORγt+ Foxp3+ cells are an independent bifunctional regulatory T cell lineage and mediate crescentic GN. J. Am. Soc. Nephrol. (2015). doi:10.1681/ASN.2014090880
52. K. Eyerich, S. Eyerich, Th22 cells in allergic disease. Allergo. J. Int. 24, 1–7 (2015)
53. I. Horie, N. Abiru, Y. Nagayama, G. Kuriya, O. Saitoh, T. Ichikawa, Y. Iwakura, K. Eguchi, T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology 150, 5135–5142 (2009)
54. F. Hayashi, M. Watanabe, T. Nanba, N. Inoue, T. Akamizu, Y. Iwatani, Association of the -31C/T functional polymorphism in the interleukine-1β gene with the intractability of Graves’ disease and the proportion of T helper type 17 cells. Clin. Exp. Immunol. 158, 281–286 (2009)
55. T. Nanba, M. Watanabe, N. Inoue, Y. Iwatani, Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19, 495–501 (2009)
56. N. Figueroa-Vega, M.A. Pérez, I. Benedicto, F. Sánchez-Madrid, R. González-Amaro, M. Marazuela, Increased circulating pro-inflammatory cytokine and Th17 lymphocytes in Hashimoto´s thyroiditis. J. Clin. Endocrinol. Metab. 95, 953–962 (2010)
57. Q. Qin, P. Liu, L. Liu, R. Wang, N. Yan, J. Yang, X. Wang, M. Pandey, J. Zhang, The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto´s thyroiditis but not in Graves´ disease. Braz. J. Med. Biol. Res. 45, 1202–1208 (2012)
58. D. Peng, B. Xu, Y. Wang, H. Guo, Y. Jiang, A high frequency of circulating Th22 and Th17 cells in patients with new onset Graves’ disease. PloS One 8, e68446 (2013)
59. D. Li, W. Cai, R. Gu, Y. Zhang, H. Zhang, K. Tang, P. Xu, F. Katirai, W. Shi, L. Wang, T. Huang, B. Huang, Th17 plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin. Immunol. 149, 411–420 (2013)
60. B. Kristensen, L. Hegedüs, H.O. Madsen, T.J. Smith, C.H. Nielsen, Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto´s thyroiditis. Clin. Exp. Immunol. 180, 58–69 (2015)
61. H. Guo, D. Peng, Y. Wang, B.C. Xu, J.S. Ni, W. Meng, Y.F. Jiang, A higher frequency of circulating IL-22+ CD4+ T cells in chinese patients with newly diagnosed Hashimoto’s thyroiditis. PloS One 9, e84545 (2014)
62. H. Xue, X. Yu, L. Ma, S. Song, Y. Li, L. Zhang, T. Yang, H. Liu, The possible role of CD4+ CD25highFoxp3+/CD4+ IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine (2015). doi:10.1007/s12020-015-0569-y
63. S. Wang, S.E. Baidoo, Y. Liu, C. Zhu, J. Tian, J. Ma, J. Tong, J. Chen, X. Tang, H. Xu, L. Lu, T cell-derived leptin contributes to increased frequency oh T helper type 17 cells in female patients with Hashimoto’s thyroiditis. Clin. Exp. Immunol. 171, 63–68 (2012)
64. Y. Liu, X. Tang, J. Tian, C. Zhu, H. Peng, K. Rui, Y. Wang, C. Mao, J. Ma, L. Lu, H. Xu, S. Wang, Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto´s thyroiditis. Int. J. Mol. Sci. 15, 21674–21686 (2014)
65. S. Leskela, A. Serrano, H. de la Fuente, A. Rodríguez-Muñoz, A. Ramos-Levi, M. Sampedro-Núñez, F. Sánchez-Madrid, R. González-Amaro, M. Marazuela, Graves’ disease is associated with defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS One 16, e0123938 (2015)
66. J.R. Li, F.Y. Hong, J.Y. Zeng, G.L. Huang, Functional interleukin-17 receptor A are present in the thyroid gland in intractable Graves’ disease. Cell. Immunol. 281, 85–90 (2013)
67. R.H. Song, Z.Y. Yu, Q. Qin, X. Wang, F.S. Muhali, L.F. Shi, W.J. Jiang, L. Xiao, D.F. Li, J.A. Zhang, Different levels of circulating Th22 cell and its related molecules in Graves’ disease and Hashimoto’s thyroiditis. Int. J. Clin. Exp. Pathol. 7, 4024–4031 (2014)
68. X. Bai, J. Sun, W. Wang, Z. Shan, H. Zheng, Y. Zhao, M. Gong, W. Teng, Increased differentiation of Th22 cells in Hashimoto’s thyroiditis. Endocr. J. 61, 1181–1190 (2014)
69. R.M. Ruggeri, P. Minciullo, S. Saitta, S. Giovanazzo, R. Certo, A. Campennì, F. Trimarchi, S. Gangemi, S. Benvenga, Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto’s thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones 13, 338–344 (2014)
70. R.M. Ruggeri, S. Saitta, M. Cristani, S. Giovanazzo, V. Tigano, F. Trimarchi, S. Benvenga, S. Gangemi, Serum interleukin-23 (IL-23) is increased in Hashimoto´s thyroiditis. Endocr. J. 61, 359–363 (2014)
71. L. Guan, X. Wang, S. Meng, L. Shi, W. Jiang, L. Xiao, X. Shi, J. Xu, J. Zhang, Increased IL-21/IL-22R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 72, 160–165 (2015)
72. S.J. Shan, R.S. Douglas, The pathophysiology of thyroid eye disease. J. Neuroophthalmol. 34, 177–185 (2014)
73. H. Wei, M. Guan, Y. Qin, C. Xie, X. Fu, F. Gao, Y. Xue, Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves’ ophthalmopathy. Endocr. J. 61, 1087–1089 (2014)
74. S.E. Kim, J.S. Yoon, K.H. Kim, S.Y. Lee, Increased serum interleukin-17 in Graves’ ophthalmopathy. Graefes Arch. Clin. Exp. Ophthalmol. 250, 1521–1526 (2012)
75. A.K. Huber, E.M. Jacobson, K. Jazdzewski, E.S. Concepcion, Y. Tomer, Interleukin (IL)-23 receptor is a major susceptibility gene for Graves’ ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 93, 1077–1081 (2008)
76. L. Zheng, P. Ye, C. Liu, The role of the IL-23/IL-17 axis in the pathogenesis of Graves’ disease. Endocr. J. 60, 591–597 (2013)
77. F. Rajaii, A.N. McCoy, T.J. Smith, Cytokines are both villains and potential therapeutic targets in thyroid-associated ophthalmopathy: From bench to bedside. Expert. Rev. Ophthalmol. 9, 227–234 (2014)
78. D. Cao, R. van Vollenhoven, L. Klareskog, C. Trollmo, V. Malmstrom, CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6, R335–R346 (2004)
79. M.R. Ehrenstein, J.G. Evans, A. Singh, S. Moore, G. Warnes, D.A. Isenberg, C. Mauri, Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200, 277–285 (2004)
80. J. Haas, A. Hug, A. Viehover, B. Fritzsching, C.S. Falk, A. Filser, T. Vetter, L. Milkova, M. Korporal, B. Fritz, B. Storch-Hagenlocher, P.H. Krammer, E. Suri-Payer, B. Wildemann, Reduced suppressive effect of CD4+ CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35, 3343–3352 (2005)
81. U. Feger, C. Luther, S. Poeschel, A. Melms, E. Tolosa, H. Wiendl, Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 147, 412–418 (2007)
82. J. Maul, C. Loddenkemper, P. Mundt, E. Berg, T. Giese, A. Stallmach, M. Zeitz, R. Duchmann, Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128, 1868–1878 (2005)
83. H. Sugiyama, R. Gyulai, E. Toichi, E. Garaczi, S. Shimada, S.R. Stevens, T.S. McCormick, K.D. Cooper, Dysfunctional blood and target tissue CD4+ CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174, 164–173 (2005)
84. H.J. Bovenschen, P.C. van de Kerkhof, P.E. van Erp, R. Woestenenk, I. Joosten, H.J. Koenen, Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17Aproducing cells and are found in lesional skin. J. Invest. Dermatol. 131, 1853–1860 (2011)
85. T.M. Brusko, C.H. Wasserfall, M.J. Clare-Salzler, D.A. Schatz, M.A. Atkinson, Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54, 1407–1414 (2005)
86. J.M. Lawson, J. Tremble, C. Dayan, H. Beyan, R.D. Leslie, M. Peakman, T.I. Tree, Increased resistance to CD4+ CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 154, 353–359 (2008)
87. B. Alvarado-Sánchez, B. Hernández-Castro, D. Portales-Pérez, L. Baranda, E. Layseca-Espinosa, C. Abud-Mendoza, A.C. Cubillas-Tejeda, R. González-Amaro, Regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 27, 110–118 (2006)
88. J.C. Crispin, A. Martínez, J. Alcocer-Varela, Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21, 273–276 (2003)
89. A. Alunno, M. Manetti, S. Caterbi, L. Ibba-Manneschi, O. Bistoni, E. Bartoloni, V. Valentini, R. Terenzi, R. Gerli, Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory th17 cells and therapeutic implications. Mediat. Inflamm. (2015). doi:10.1155/2015/751793
90. S. Alvermann, C. Hennig, O. Stüve, H. Wiendl, M. Stangel, Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers. JAMA Neurol. 71, 905–912 (2014)
91. J.S. Tzartos, M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, M.M. Esiri, L. Fugger, Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172, 146–155 (2008)
92. C.S. Catana, I. Berindan Neagoe, V. Cozma, C. Magdas, F. Tabaran, D.L. Dumitrascu, Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 21, 5823–5830 (2015)
93. J.L. Harden, J.G. Krueger, A.M. Bowcock, The immunogenetics of psoriasis: a comprehensive review. J. Autoimmun. (2015). doi:10.1016/j.jaut.2015.07.008
94. L. Reinert-Hartwall, J. Honkanen, H.M. Salo, J.K. Nieminen, K. Luopajärvi, T. Härkönen, R. Veijola, O. Simell, J. Ilonen, A. Peet, V. Tillmann, M. Knip, O. Vaarala, DIABIMMUNE Study Group, Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans. J. Immunol. 194, 68–75 (2015)
95. M.S. Maddur, P. Miossec, S.V. Kaveri, J. Bayry, Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 181, 8–18 (2012)